335 related articles for article (PubMed ID: 37033478)
1. Bidirectional effects of oral anticoagulants on gut microbiota in patients with atrial fibrillation.
Li W; Li C; Ren C; Zhou S; Cheng H; Chen Y; Han X; Zhong Y; Zhou L; Xie D; Liu H; Xie J
Front Cell Infect Microbiol; 2023; 13():1038472. PubMed ID: 37033478
[TBL] [Abstract][Full Text] [Related]
2. Role of cardiovascular implantable electronic devices in delivering individualized disease-guided management of patients with non-valvular atrial fibrillation and high bleeding risk.
Mascarenhas DAN; Sharma M; Ziegler PD; Kantharia BK
Acta Cardiol; 2019 Apr; 74(2):131-139. PubMed ID: 29863432
[TBL] [Abstract][Full Text] [Related]
3. Continuation or discontinuation of oral anticoagulants after HAS-BLED scores increase in patients with atrial fibrillation.
Chao TF; Chan YH; Chiang CE; Tuan TC; Liao JN; Chen TJ; Lip GYH; Chen SA
Clin Res Cardiol; 2022 Jan; 111(1):23-33. PubMed ID: 33704551
[TBL] [Abstract][Full Text] [Related]
4. Effect of Mailing Educational Material to Patients With Atrial Fibrillation and Their Clinicians on Use of Oral Anticoagulants: A Randomized Clinical Trial.
Pokorney SD; Cocoros N; Al-Khalidi HR; Haynes K; Li S; Al-Khatib SM; Corrigan-Curay J; Driscoll MR; Garcia C; Calvert SB; Harkins T; Jin R; Knecht D; Levenson M; Lin ND; Martin D; McCall D; McMahill-Walraven C; Nair V; Parlett L; Petrone A; Temple R; Zhang R; Zhou Y; Platt R; Granger CB
JAMA Netw Open; 2022 May; 5(5):e2214321. PubMed ID: 35639381
[TBL] [Abstract][Full Text] [Related]
5. Prognostic Significance of Nuisance Bleeding in Anticoagulated Patients With Atrial Fibrillation.
O'Brien EC; Holmes DN; Thomas LE; Fonarow GC; Allen LA; Gersh BJ; Kowey PR; Singer DE; Ezekowitz MD; Naccarelli GV; Ansell JE; Chan PS; Mahaffey KW; Go AS; Freeman JV; Reiffel JA; Peterson ED; Piccini JP; Hylek EM
Circulation; 2018 Aug; 138(9):889-897. PubMed ID: 29678813
[TBL] [Abstract][Full Text] [Related]
6. Effectiveness and Safety of Anticoagulation Therapy in Frail Patients With Atrial Fibrillation.
Kim D; Yang PS; Sung JH; Jang E; Yu HT; Kim TH; Uhm JS; Kim JY; Pak HN; Lee MH; Lip GYH; Joung B
Stroke; 2022 Jun; 53(6):1873-1882. PubMed ID: 35109686
[TBL] [Abstract][Full Text] [Related]
7. Risk factors for thromboembolic and bleeding events in anticoagulated patients with atrial fibrillation: the prospective, multicentre observational PREvention oF thromboembolic events - European Registry in Atrial Fibrillation (PREFER in AF).
Rohla M; Weiss TW; Pecen L; Patti G; Siller-Matula JM; Schnabel RB; Schilling R; Kotecha D; Lucerna M; Huber K; De Caterina R; Kirchhof P
BMJ Open; 2019 Mar; 9(3):e022478. PubMed ID: 30928922
[TBL] [Abstract][Full Text] [Related]
8. It can be safe to discontinue oral anticoagulants after successful atrial fibrillation ablation: A systematic review and meta-analysis of cohort studies.
Wang X; Li M; Wang X; Zhang Z
Medicine (Baltimore); 2023 Oct; 102(42):e35518. PubMed ID: 37861532
[TBL] [Abstract][Full Text] [Related]
9. Net benefit of oral anticoagulants in patients with atrial fibrillation and active cancer: a nationwide cohort study.
Atterman A; Friberg L; Asplund K; Engdahl J
Europace; 2020 Jan; 22(1):58-65. PubMed ID: 31750897
[TBL] [Abstract][Full Text] [Related]
10. The HAS-BLED score has better prediction accuracy for major bleeding than CHADS2 or CHA2DS2-VASc scores in anticoagulated patients with atrial fibrillation.
Roldán V; Marín F; Manzano-Fernández S; Gallego P; Vílchez JA; Valdés M; Vicente V; Lip GY
J Am Coll Cardiol; 2013 Dec; 62(23):2199-204. PubMed ID: 24055744
[TBL] [Abstract][Full Text] [Related]
11. Oral Anticoagulation for Patients With Atrial Fibrillation on Long-Term Hemodialysis.
Kuno T; Takagi H; Ando T; Sugiyama T; Miyashita S; Valentin N; Shimada YJ; Kodaira M; Numasawa Y; Briasoulis A; Burger A; Bangalore S
J Am Coll Cardiol; 2020 Jan; 75(3):273-285. PubMed ID: 31976865
[TBL] [Abstract][Full Text] [Related]
12. Development of a shared decision-making tool to assist patients and clinicians with decisions on oral anticoagulant treatment for atrial fibrillation.
Kaiser K; Cheng WY; Jensen S; Clayman ML; Thappa A; Schwiep F; Chawla A; Goldberger JJ; Col N; Schein J
Curr Med Res Opin; 2015 Dec; 31(12):2261-72. PubMed ID: 26390360
[TBL] [Abstract][Full Text] [Related]
13. Risks and benefits of anticoagulation in atrial fibrillation: insights from the Outcomes Registry for Better Informed Treatment of Atrial Fibrillation (ORBIT-AF) registry.
Cullen MW; Kim S; Piccini JP; Ansell JE; Fonarow GC; Hylek EM; Singer DE; Mahaffey KW; Kowey PR; Thomas L; Go AS; Lopes RD; Chang P; Peterson ED; Gersh BJ;
Circ Cardiovasc Qual Outcomes; 2013 Jul; 6(4):461-9. PubMed ID: 23759473
[TBL] [Abstract][Full Text] [Related]
14. Underuse of oral anticoagulants in privately insured patients with atrial fibrillation: A population being targeted by the IMplementation of a randomized controlled trial to imProve treatment with oral AntiCoagulanTs in patients with Atrial Fibrillation (IMPACT-AFib).
Al-Khatib SM; Pokorney SD; Al-Khalidi HR; Haynes K; Garcia C; Martin D; Goldsack JC; Harkins T; Cocoros NM; Lin ND; Lipowicz H; McCall D; Nair V; Parlett L; McMahill-Walraven CN; Platt R; Granger CB
Am Heart J; 2020 Nov; 229():110-117. PubMed ID: 32949986
[TBL] [Abstract][Full Text] [Related]
15. Assessing the Appropriateness of Oral Anticoagulation for Atrial Fibrillation in Advanced Frailty: Use of Stroke and Bleeding Risk-Prediction Models.
O'Caoimh R; Igras E; Ramesh A; Power B; O'Connor K; Liston R
J Frailty Aging; 2017; 6(1):46-52. PubMed ID: 28244558
[TBL] [Abstract][Full Text] [Related]
16. Drug Utilization Pattern of Oral Anticoagulants in Patients with Atrial Fibrillation: A Nationwide Population-Based Study in Korea.
Lee MY; Han S; Bang OY; On YK; Jang SW; Han S; Ryu J; Park YJ; Kang S; Suh HS; Kim YH
Adv Ther; 2022 Jul; 39(7):3112-3130. PubMed ID: 35524839
[TBL] [Abstract][Full Text] [Related]
17. Role of insertable cardiac monitors in anticoagulation therapy in patients with atrial fibrillation at high risk of bleeding.
Mascarenhas DA; Farooq MU; Ziegler PD; Kantharia BK
Europace; 2016 Jun; 18(6):799-806. PubMed ID: 26614520
[TBL] [Abstract][Full Text] [Related]
18. Contemporary Trends in Oral Anticoagulant Prescription in Atrial Fibrillation Patients at Low to Moderate Risk of Stroke After Guideline-Recommended Change in Use of the CHADS
Katz DF; Maddox TM; Turakhia M; Gehi A; O'Brien EC; Lubitz SA; Turchin A; Doros G; Lei L; Varosy P; Marzec L; Hsu JC
Circ Cardiovasc Qual Outcomes; 2017 May; 10(5):. PubMed ID: 28506981
[TBL] [Abstract][Full Text] [Related]
19. Incidence and outcomes of patients with atrial fibrillation and major bleeding complications: from the TREAT-AF study.
Perino AC; Kaiser DW; Lee RJ; Fan J; Askari M; Schmitt SK; Turakhia MP
J Interv Card Electrophysiol; 2021 Oct; 62(1):133-142. PubMed ID: 32986177
[TBL] [Abstract][Full Text] [Related]
20. Long-term outcome and risk factors associated with events in patients with atrial fibrillation treated with oral anticoagulants: The ASSAF-K registry.
Hatori Y; Sakai H; Hatori N; Kunishima T; Namiki A; Shimizu M; Toyosaki N; Kuwajima M; Sato N;
J Cardiol; 2023 Apr; 81(4):385-389. PubMed ID: 36109256
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
